Lucinda Warren
Vice President, Business Development
Neuroscience
The Janssen Pharmaceutical Companies of Johnson & Johnson
Portugal
Biography
Lucinda heads the Neuroscience Business Development Team which includes scientific finding, licensing transactions, mergers, acquisition, out licensing and alliance management. With over 23 years of broad industry experience, Lucinda began her Pharma career in Canada. In 1999, she joined the Johnson & Johnson Family of Companies and has held various USA and Global roles of increasing responsibilities, including Sales, Marketing, New Product Development, Alliance Management, and Business Development Leadership. Lucinda has been responsibility for the leadership and oversight of some of Janssen’s longest and largest global commercial alliances in addition to leading the global integration of Johnson & Johnson’s single largest asset REMICADE®, back into the organization in 2011. Just prior to joining the Janssen Development Leadership Team, Lucinda led the Immunology Business Unit in Australia, returning to the USA in 2014 as VP Alliance Management, Janssen, responsible for leading the Pharmaceutical portfolio of collaborations. Lucinda earned her BSc from the University of Alberta.
Research Interest
Research interest is in neurosciences
